Jintrotide 0.1mg injection 1 Ampx1 ml

Warnings

Pregnancy
This medication is contraindicated in pregnancy.

Lactation
This medication is contraindicated in lactating females

Precautions
therapeutic effects of this medication might diminish suddenly. Patients with diabetes may show reduced hypoglycemic (low blood sugar) requirement. If patients using this medication in carcinoid tumor don’t get results within one week should discontinue

Expert Advice

This medication is indicated in patients with gastro-entero-pancreatic endocrine (GEP) (stomach, intestine and pancreatic) tumors, carcinoid tumors (slow growing cancer growing throughout the body), patients who go through pancreatic surgery. It is a short term treatment for acromegaly and long term treatment in patients in whom dopamine agonist and radiotherapy are ineffective.

Side Effects

Patients administered with this medication may experience injection site reaction, gastrointestinal (stomach and intestine) problems, gallstones (stones in gall bladder), biliary colic (pain in abdomen), repeated hyperglycemia (rise in blood sugar), hypoglycemia (decrease in blood sugar), hair loss, hepatic (liver) dysfunction and acute pancreatitis (inflammation of pancreas)